Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 1284 clinical trials
A Hospital-at-Home Pilot in Singapore

Hospital-at-home models seek to address the impending shortage of hospital beds by reimagining the way we deliver acute hospital-level care - substituting the ward for a patient's home. Such programmes have been well established in other countries such as Australia, Europe and USA to be a less costly way to …

  • 16 Apr, 2021
  • 2 locations
Early Life Cohort in Papua Indonesia (ELIPI Study) (ELIPI)

Malaria remains an important cause of illness in young infants. Our clinical and epidemiological studies in Papua (Indonesia) have shown the magnitude of malaria morbidity in infants in the first 5 years of life, including recurrent episodes of malaria, anaemia, malnutrition and coinfection. Together these contribute significantly morbidity in early …

Accepts healthy volunteers
vivax malaria
  • 12 May, 2022
  • 1 location
The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure

HBV-related acute-on-chronic liver failure (ACLF) is a clinical syndrome defined as acute hepatic insult with diagnosed or undiagnosed chronic liver disease. Current clinical guidelines advocate oral antiviral treatment in HBV-related ACLF. However, no conclusion on which nucleoside analogue is the most satisfactory drug for the treatment of HBV-related liver failure …

nucleoside analogue
hepatitis b surface antigen
  • 07 Feb, 2022
  • 2 locations
Disease Loads and Status of Treatment

The aim of study is to evaluate the current prevalence of HDV infection, and comprehensively analyze the interaction between HDV and HBV infections in the era of NAs in Taiwan. Investigators plan to set up a platform for HDV positive patients in Taiwan to invite sites or hepatologists who are …

hepatitis b core antibody
  • 13 Mar, 2022
  • 1 location
Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation

A prospective cohort study to evaluate the response to COVID-19 vaccine in liver transplantation patients.

  • 24 Mar, 2022
  • 1 location
Evaluation, Treatment, and Follow-up of Patients With Lyme Disease

This study is designed to establish a population of patients with Lyme disease for evaluation, treatment and follow-up to learn more about the infection. Patients with active Lyme disease may be eligible for this study. Participants will have a medical history and physical examination and diagnostic evaluations as appropriate to …

tissue cultures
skin biopsy
  • 13 Jun, 2022
  • 1 location
Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra

Recent research evidence shows that levels of antibodies acquierd post vacunation against SARS-Cov-2 decrease over time as well as the efficacy to control the infection, additionally in a multicenter study carried out in 2020 were evidenced differences in the time it took to decrease the antibodies according to the type …

Accepts healthy volunteers
  • 14 Mar, 2022
  • 1 location
Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

Background There are very few documents to help young adults living with advanced cancer discuss their concerns and end-of-life preferences. A new document, Voicing My CHOiCES, allows young adults to explain what kind of care they would want if they became unable to communicate or make medical decisions on their …

primary cancer
advanced cancer
chronic disease
  • 19 Jun, 2022
  • 10 locations
BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment

In this Italian observational study the antibody titer reactogenicity to Pfizer Severe Acute Respiratory Syndrome (SARS) - Coronavirus (CoV-2) RNA vaccine in cancer patients under active antitumor treatment will be evaluated at 21 and 42 days and after 6 months. Furthermore patients safety will be monitored. Factors affecting immunogenicity (or …

primary cancer
cancer treatment
  • 29 Jun, 2021
  • 1 location
Survey of Human Rabies Immune Globulin Safety in Children

This observational study will be conducted across the Houston Methodist system, including all hospital-based and freestanding emergency departments (ED), and up to 4 additional sites in the United States. The safety of human rabies immune globulin (HRIG) 300 IU/mL product (HyperRAB®) in pediatric patients has not been fully established. The …

  • 08 Jun, 2022
  • 1 location